Rasagiline, a novel monoamine oxidase-B
โ
Saleh Abu-Raya; Eran Blaugrund; Victoria Trembovler; Philip Lazarovici
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 122 KB
๐ 1 views
Rasagiline (N-propargyl-1R-aminoindan) is a novel, potent, selective, and irreversible inhibitor of monoamine oxidase B (MAO-B), currently in Phase III trials for the treatment of Parkinson disease (PD). Rasagiline was shown to have neuroprotective properties in various in vitro and in vivo models i